Is QPTFF or RYLD a better dividend investment in 2026?

QPTFF currently yields 6578.95% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: QPTFF offers higher current income.

What is the dividend yield difference between QPTFF and RYLD?

QPTFF has a forward dividend yield of 6578.95% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 6566.81 percentage points.

Home › Compare › QPTFF vs RYLD

QPTFF vs RYLD: Dividend Comparison 2026

QPTFF yields 6578.95% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 QPTFF wins by $903160944306728.13M in total portfolio value

INVESTMENT

TIME HORIZON10 years

QPTFF

● Live price

6578.95%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$903160944306728.13M

Annual income

$876,939,829,008,324,100,000.00

Full QPTFF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — QPTFF vs RYLD

📍 QPTFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	QPTFF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, QPTFF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

QPTFF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QPTFF

Annual income on $10K today (after 15% tax)

$559,210.53/yr

After 10yr DRIP, annual income (after tax)

$745,398,854,657,075,400,000.00/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, QPTFF beats the other by $745,398,854,657,075,400,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QPTFF + RYLD for your $10,000?

QPTFF: 50%RYLD: 50%

100% RYLD50/50100% QPTFF

Portfolio after 10yr

$451580472153364.06M

Annual income

$438,469,914,504,162,050,000.00/yr

Blended yield

97.10%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QPTFF buys

RYLD buys

No recent congressional trades found for QPTFF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricQPTFFRYLD

Forward yield	6578.95% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$903160944306728.13M ✓	$44.5K
Annual income after 10y	$876,939,829,008,324,100,000.00 ✓	$2,587.35
Total dividends collected	$901400901751488.63M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: QPTFF vs RYLD ($10,000, DRIP)

Year	QPTFF Portfolio	QPTFF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$668,595	$657,894.74	$11,914	$1,213.65	+$656.7K → QPTFF
2	$41,824,271	$41,108,874.62	$14,099	$1,351.30	+$41.81M → QPTFF
3	$2,448,103,158	$2,403,351,188.44	$16,580	$1,494.55	+$2448.09M → QPTFF
4	$134,091,931,604	$131,472,461,224.39	$19,384	$1,642.61	+$134091.91M → QPTFF
5	$6,873,616,037,527	$6,730,137,670,710.89	$22,535	$1,794.70	+$6873616.01M → QPTFF
6	$329,775,376,912,396	$322,420,607,752,241.75	$26,063	$1,950.00	+$329775376.89M → QPTFF
7	$14,809,652,943,541,940	$14,456,793,290,245,678.00	$29,995	$2,107.69	+$14809652943.51M → QPTFF
8	$622,603,404,175,321,200	$606,757,075,525,731,300.00	$34,361	$2,266.99	+$622603404175.29M → QPTFF
9	$24,505,715,232,153,338,000	$23,839,529,589,685,744,000.00	$39,194	$2,427.12	+$24505715232153.30M → QPTFF
10	$903,160,944,306,728,100,000	$876,939,829,008,324,100,000.00	$44,525	$2,587.35	+$903160944306728.13M → QPTFF

QPTFF vs RYLD: Complete Analysis 2026

QPTFF — Stock

Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, an anti-CA-125 antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications; skin penetrating active molecules for cosmetic and pharmaceutical use; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

Full QPTFF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this QPTFF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QPTFF vs SCHD QPTFF vs JEPI QPTFF vs O QPTFF vs KO QPTFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.